Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Organic Chemicals --- Models, Molecular. --- Molecular Structure. --- Organic compounds --- Chemical templates. --- Composés organiques --- chemical synthesis. --- Synthesis. --- Synthèse --- Chemistry. --- Chemistry, inorganic. --- Chemistry, Organic. --- Polymers. --- Condensed matter. --- Organic Chemistry. --- Inorganic Chemistry. --- Condensed Matter. --- Polymer Sciences. --- Chemistry --- Physical Sciences & Mathematics --- Biochemistry --- Condensed materials --- Condensed media --- Condensed phase --- Materials, Condensed --- Media, Condensed --- Phase, Condensed --- Polymere --- Polymeride --- Polymers and polymerization --- Organic chemistry --- Inorganic chemistry --- Inorganic chemistry. --- Organic chemistry. --- Condensed Matter Physics. --- Chemical templates --- Chemistry, Organic --- Chemistry, Synthetic organic --- Organic synthesis (Chemistry) --- Synthetic organic chemistry --- Molecular templates --- Templates (Chemistry) --- Molecules --- Synthesis --- Macromolecules --- Inorganic compounds --- Polymers  . --- Liquids --- Matter --- Solids --- Organic compounds - Synthesis. --- Organic Chemicals - chemical synthesis.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Chalcogens. --- Carboxylic acids. --- Tellurium. --- Chemistry. --- Chemistry, inorganic. --- Chemistry, Organic. --- Organic Chemistry. --- Inorganic Chemistry. --- Chalcogens --- Carboxylic Acids --- Organic Chemicals --- Elements --- Inorganic Chemicals --- Chemicals and Drugs --- Biochemistry --- Chemistry --- Physical Sciences & Mathematics --- Chemicals, Inorganic --- Acids, Carboxylic --- Chemicals, Organic --- Organic chemistry --- Inorganic chemistry --- Group 16 Elements --- Elements, Group 16 --- Inorganic chemistry. --- Organic chemistry. --- Inorganic compounds

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This report deals with 2 4 6-tribromophenol (2 4 6-TBP) and other simple brominated phenols with a single benzene ring. However information on toxicity ecotoxicity and environmental fate on bromophenols other than 2 4 6-TBP is very limited. On the basis of the very limited data on concentrations of bromophenols in waters and sediment the present risk to aquatic organisms from 2 4 6-TBP in sediment would appear to be low. Insufficient data are available to make a meaningful risk assessment for other brominated phenols and for all brominated phenols in the terrestrial environment.

Fluorine. --- Nitration. --- Phenols. --- Environmental Pollution --- Risk --- Inorganic Chemicals --- Risk Management --- Organic Chemicals --- Epidemiologic Measurements --- Organization and Administration --- Chemicals and Drugs --- Probability --- Public Health --- Health Services Administration --- Statistics as Topic --- Environment and Public Health --- Epidemiologic Methods --- Health Care --- Health Care Evaluation Mechanisms --- Quality of Health Care --- Investigative Techniques --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Health Care Quality, Access, and Evaluation --- Risk Assessment --- Phenols --- Environmental Exposure --- Bromine Compounds

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Continuous rigorous research in basic neurosciences and in clinical studies has enormously increased our knowledge of the neurobiological basis of mental functions and of the neuronal dysfunctions underlying such diseases as schizophrenia, depression, attention deficit disorder, and Parkinson's disease. A transmitter system does not work in isolation, it interacts with other transmitters and the balance between several transmitter determines the outcome, either physiological or pathological. Such a critical balance exists between dopamine and glutamate, which in many brain areas play functionally opposing roles. In Dopamine and Glutamate in Psychiatric Disorders, a panel of neurochemists, pharmacologists, experimental psychologists, and clinicians summarizes our current understanding of the interactive role of dopamine and glutamate in psychiatric diseases and from that develops novel therapeutic strategies and possibilities for the future. Among the new ideas presented are hypotheses on the role of dopamine and glutamate in aggression, the glutamate system in anxiety disorders, glutamate and neurodegeneration, on the origin, progression, and cognitive aspects of Parkinson's disease. Additional chapters offer illuminating insights into a variety of psychiatric diseases, including attention deficit hyperactivity disorder, stress, aggression, addiction, schizophrenia, depression, social phobias, dementias, bulimia, and neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Each chapter summarizes the prevalence and symptoms of the disease and explains the involvement of dopamine and/or glutamate systems using the newer molecular approaches such as transgenic knockout or knockin mice and recent brain imaging techniques. The authors also offer a critical selection and evaluation of relevant literature and a description of future directions for new therapy development. Path-breaking and insightful, Dopamine and Glutamate in Psychiatric Disorders offers behavioral pharmacologists, neurobiologists, and clinicians an enlightening review of the neurobiological basis and treatment strategies of today's most important psychiatric and neurological diseases.

Medicine & Public Health. --- Psychiatry. --- Medicine. --- Médecine --- Psychiatrie --- Antidepressive Agents -- pharmacology. --- Antipsychotic Agents -- pharmacology. --- Dopamine -- Pathophysiology. --- Glutamate -- Pathophysiology. --- Mental Disorders -- drug therapy. --- Mental Disorders -- etiology. --- Nervous System Diseases -- drug therapy. --- Nervous System Diseases -- etiology. --- Neuropsychiatry. --- Neurotransmitter receptors. --- Neuropsychiatry --- Dopamine --- Glutamate --- Neurotransmitter receptors --- Tranquilizing Agents --- Receptors, Catecholamine --- Amino Acids, Dicarboxylic --- Psychiatry and Psychology --- Psychotropic Drugs --- Excitatory Amino Acids --- Receptors, Amino Acid --- Diseases --- Amino Acids, Acidic --- Catecholamines --- Central Nervous System Agents --- Amino Acids --- Receptors, Biogenic Amine --- Central Nervous System Depressants --- Biogenic Monoamines --- Receptors, Neurotransmitter --- Receptors, G-Protein-Coupled --- Amines --- Amino Acids, Peptides, and Proteins --- Receptors, Cell Surface --- Biogenic Amines --- Organic Chemicals --- Physiological Effects of Drugs --- Therapeutic Uses --- Pharmacologic Actions --- Membrane Proteins --- Chemicals and Drugs --- Proteins --- Chemical Actions and Uses --- Antidepressive Agents --- Antipsychotic Agents --- Mental Disorders --- Glutamic Acid --- Receptors, Dopamine --- Receptors, Glutamate --- Nervous System Diseases --- Medicine --- Psychiatry --- Health & Biological Sciences --- Neurology --- Psychiatry - General --- Pathophysiology --- Glutamic acid --- Pathophysiology. --- Behavioral neurology --- Medicine and psychology --- Mental health --- Psychology, Pathological --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Excitatory amino acids --- Umami (Taste) --- Biogenic amines --- Bromocriptine --- Neurotransmitters --- Biological psychiatry --- Cell receptors --- Hormone receptors --- Neural receptors